5VX1
| Bak L100A | 分子名称: | Bcl-2 homologous antagonist/killer | 著者 | Brouwer, J.M, Colman, P.M, Czabotar, P.E. | 登録日 | 2017-05-23 | 公開日 | 2017-11-15 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (1.224 Å) | 主引用文献 | Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. Mol. Cell, 68, 2017
|
|
8H69
| Cryo-EM structure of influenza RNA polymerase | 分子名称: | Polymerase acidic protein, Polymerase basic protein 2, RNA (5'-R(*UP*AP*AP*AP*CP*UP*CP*CP*UP*GP*CP*UP*UP*UP*UP*GP*CP*U)-3'), ... | 著者 | Li, H, Wu, Y, Liang, H, Liu, Y. | 登録日 | 2022-10-16 | 公開日 | 2023-06-28 | 最終更新日 | 2023-11-15 | 実験手法 | ELECTRON MICROSCOPY (3.7 Å) | 主引用文献 | An intermediate state allows influenza polymerase to switch smoothly between transcription and replication cycles. Nat.Struct.Mol.Biol., 30, 2023
|
|
7V99
| catalytic core of human telomerase holoenzyme | 分子名称: | Histone H2A type 1-B/E, Histone H2B type 1-K, Primer DNA, ... | 著者 | Wan, F, Ding, Y, Yang, L, Wu, Z, Wu, J, Lei, M. | 登録日 | 2021-08-24 | 公開日 | 2022-03-30 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (3.54 Å) | 主引用文献 | Zipper head mechanism of telomere synthesis by human telomerase. Cell Res., 31, 2021
|
|
7V9A
| biogenesis module of human telomerase holoenzyme | 分子名称: | H/ACA ribonucleoprotein complex subunit 1, H/ACA ribonucleoprotein complex subunit 2, H/ACA ribonucleoprotein complex subunit 3, ... | 著者 | Wan, F, Ding, Y, Yang, L, Wu, Z, Wu, J, Lei, M. | 登録日 | 2021-08-24 | 公開日 | 2022-03-30 | 最終更新日 | 2024-06-12 | 実験手法 | ELECTRON MICROSCOPY (3.94 Å) | 主引用文献 | Zipper head mechanism of telomere synthesis by human telomerase. Cell Res., 31, 2021
|
|
5VWY
| |
5VX3
| Bcl-xL in complex with Bim-h3Pc-RT | 分子名称: | 1,2-ETHANEDIOL, Bcl-2-like protein 1, Bcl-2-like protein 11 | 著者 | Cowan, A.D, Brouwer, J.M, Colman, P.M, Czabotar, P.E. | 登録日 | 2017-05-23 | 公開日 | 2017-11-15 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (1.945 Å) | 主引用文献 | Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. Mol. Cell, 68, 2017
|
|
6WBS
| Human CFTR first nucleotide binding domain with dF508/V510D | 分子名称: | ADENOSINE-5'-TRIPHOSPHATE, Cystic fibrosis transmembrane conductance regulator, MAGNESIUM ION | 著者 | Simon, K.S, Kothe, M, Hilbert, B, Batchelor, J.D, Hurlbut, G.D. | 登録日 | 2020-03-27 | 公開日 | 2021-04-07 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.857 Å) | 主引用文献 | Determining the Molecular Mechanism of Suppressor Mutation V510D and the Contribution of Helical Unraveling to the dF508-CFTR Defect To Be Published
|
|
6WQF
| |
5WWO
| Crystal structure of Enp1 | 分子名称: | Essential nuclear protein 1, Protein LTV1 | 著者 | Ye, K, Zhang, W. | 登録日 | 2017-01-03 | 公開日 | 2017-06-28 | 最終更新日 | 2024-03-20 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Molecular architecture of the 90S small subunit pre-ribosome Elife, 6, 2017
|
|
5WYJ
| Cryo-EM structure of the 90S small subunit pre-ribosome (Dhr1-depleted, Enp1-TAP, state 1) | 分子名称: | 13 kDa ribonucleoprotein-associated protein, 18S ribosomal RNA, 40S ribosomal protein S1-A, ... | 著者 | Ye, K, Zhu, X, Sun, Q. | 登録日 | 2017-01-13 | 公開日 | 2017-03-29 | 最終更新日 | 2019-10-09 | 実験手法 | ELECTRON MICROSCOPY (8.7 Å) | 主引用文献 | Molecular architecture of the 90S small subunit pre-ribosome. Elife, 6, 2017
|
|
5WWN
| Crystal structure of Tsr1 | 分子名称: | Ribosome biogenesis protein TSR1, SULFATE ION | 著者 | Ye, K, Wang, B. | 登録日 | 2017-01-03 | 公開日 | 2017-06-28 | 最終更新日 | 2024-03-20 | 実験手法 | X-RAY DIFFRACTION (2.805 Å) | 主引用文献 | Molecular architecture of the 90S small subunit pre-ribosome Elife, 6, 2017
|
|
5WXM
| Crystal structure of the Imp3 and Mpp10 complex | 分子名称: | SULFATE ION, U3 small nucleolar RNA-associated protein MPP10, U3 small nucleolar ribonucleoprotein protein IMP3 | 著者 | Ye, K, Zheng, S. | 登録日 | 2017-01-07 | 公開日 | 2017-06-28 | 実験手法 | X-RAY DIFFRACTION (2.304 Å) | 主引用文献 | Molecular architecture of the 90S small subunit pre-ribosome Elife, 6, 2017
|
|
5WWM
| |
5WYL
| |
5WYK
| Cryo-EM structure of the 90S small subunit pre-ribosome (Mtr4-depleted, Enp1-TAP) | 分子名称: | 13 kDa ribonucleoprotein-associated protein, 18S ribosomal RNA, 40S ribosomal protein S1-A, ... | 著者 | Ye, K, Zhu, X, Sun, Q. | 登録日 | 2017-01-13 | 公開日 | 2017-03-29 | 最終更新日 | 2017-05-17 | 実験手法 | ELECTRON MICROSCOPY (4.5 Å) | 主引用文献 | Molecular architecture of the 90S small subunit pre-ribosome. Elife, 6, 2017
|
|
5WY3
| |
5VWZ
| Bak in complex with Bim-h3Pc | 分子名称: | 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL, AMMONIUM ION, Bcl-2 homologous antagonist/killer, ... | 著者 | Brouwer, J.M, Colman, P.M, Czabotar, P.E. | 登録日 | 2017-05-23 | 公開日 | 2017-11-15 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.622 Å) | 主引用文献 | Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. Mol. Cell, 68, 2017
|
|
5WXL
| |
5VWW
| Bak core latch dimer in complex with Bim-RT - Tetragonal | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, BROMIDE ION, Bcl-2 homologous antagonist/killer, ... | 著者 | Brouwer, J.M, Colman, P.M, Czabotar, P.E. | 登録日 | 2017-05-23 | 公開日 | 2017-11-15 | 最終更新日 | 2024-03-13 | 実験手法 | X-RAY DIFFRACTION (2.802 Å) | 主引用文献 | Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. Mol. Cell, 68, 2017
|
|
5LBV
| Structural basis of zika and dengue virus potent antibody cross-neutralization | 分子名称: | SODIUM ION, alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, envelope protein E | 著者 | Barba-Spaeth, G. | 登録日 | 2016-06-17 | 公開日 | 2016-07-06 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature, 536, 2016
|
|
4QMF
| |
8S4H
| |
8S4K
| Crystal structure of Fab-2B1 in complex with rocuronium | 分子名称: | 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, Fab-2B1 VH, Fab-2B1 VL, ... | 著者 | Saul, F.A, Haouz, A, Bruhns, P. | 登録日 | 2024-02-21 | 公開日 | 2024-09-18 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models. Sci Transl Med, 16, 2024
|
|
7NRJ
| |
7O5T
| |